| abstract |
the present invention relates to a new pyrrolopyridine compound represented by the chemical formula i, a racemate or a stereoisomer thereof or a pharmaceutically acceptable salt thereof; and a method for preparing it. a compound represented by the chemical formula i shows high selectivity and antiviral activity against human immunodeficiency virus (hiv), with low toxicity; therefore, it is useful as a therapeutic agent for viral infection, in particular, HIV infection. |